Plenary Sessions
Gemma Salvado
Post-doctoral researcher at Lund University (Sweden)
+ INFO
Introductive Talk Recent Advancements in European Research
Jonathan Schott
Professor of Neurology, UCL Dementia Research Centre (UK)
+ INFO
Plenary #1 Using imaging to detect and understand preclinical dementia: insights from the British 1946 birth cohort
Renaud La Joie
Assistant Professor, Memory and Aging Center, UCSF (USA)
+ INFO
Plenary #2 Neuroimaging in the era of anti-amyloid therapies
symposium
1. New imaging techniques and innovative approaches
- #1 Meera Srikrishna
University of Gothenburg, Sweden
« CT-based imaging markers for idiopathic normal pressure hydrocephalus obtained using deep learning: association with MRI-based radiological markers and diagnosis » - #2 Heidi Jacobs
Maastricht University & Massachusetts General Hospital, The Netherlands /USA
« Locus coeruleus imaging to identify
pre-preclinical Alzheimer’s disease » - #3 Mistuko Nakajima
University College London, United-Kingdom
« Differential cortical layer vulnerability in
premanifest Huntington’s disease » - #4 Joana Pereira
Karolinska Institutet, Sweden
« Understanding the role of the neuromodulatory nucleiin brain connectivity in aging and neurodegeneration »
2. AD subtypes and differential diagnosis
- #5 Jacob Vogel
Lund University, Sweden
« An update on Alzheimer’s disease tau subtypes: clinical and biological insights » - #6 Rik Ossenkoppele
VU Amsterdam & Lund University, The Netherlands/Sweden
« AT(N) imaging in atypical variants of Alzheimer’s disease » - #7 Alexandre Bejanin
IIB Sant Pau, Spain
« Neuroimaging of Alzheimer’s and vascular pathologies in Down syndrome » - #8 Gérard Bischof
University Hospital Cologne, Germany
« 18F-PI2620 Tau PET in AD and Non-AD
Neurodegenerative Diseases » - #9 Michela Pievani
RCCS Centro San Giovanni di Dio, Italy
« Brain networks connectivity in AD and FTD »
3. Opportunities and Challenges in Data Sharing in European Neuroimaging
- #10 Julia Neitzel
Erasmus MC University Medical Center Rotterdam, The Netherlands
« Data sharing strategies in the Rotterdam Study » - #11 Oliver Speck
Otto-von-Guericke University Magdeburg, DZNE Magdeburg, Germany
« Opportunities and Challenges in multicenter
MR neuroimaging studies » - #12 Ludovica Griffanti
University of Oxford, United Kingdom
« From ‘big data’ to the clinic: implementing the UK Biobank imaging framework for memory clinic patients » - #13 Lyduine Collij
Amsterdam UMC & Lund University, The Netherlands/Sweden
« From AMYPAD to EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectorie » - #14 Kristine Walhovd
University of Oslo, Norway
« Longitudinal neuroimaging studies- Lifebrain and beyond »
4. The present and future of PET imaging
- #15 Agneta Nordberg
NVS,Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Sweden
« PET imaging markers in neurodegenerative diseases – the present and future » - #16 Bernard Hanseeuw
Cliniques Universitaires Saint-Luc, UCLouvain, Belgium / Massachusetts General Hospital, Harvard Medical School, USA
« Tau-PET imaging: From research data to Appropriate Use Criteria » - #17 Maura Malpetti
Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK
« PET imaging of synaptic health across
neurodegenerative diseases » - #18 Julien Lagarde
Hôpital Sainte-Anne, Université Paris-Cité,
Université Paris-Saclay, France
« PET imaging of neuroinflammation in AD and potential implications in therapeutic trials »
#19 Ruben Smith
Lund University / Skåne University Hospital, Sweden
« LAlpha-synuclein PET imaging »
5. Neuroimaging correlates of biofluids and neuropathology
- #20 Laura Jonkman
Amsterdam UMC, the Netherlands
« MRI signatures of neuropathology » - #21 Valentina Perosa
Massachusetts General Hospital, Harvard Medical School, USA
« Leveraging high-resolution ex vivo neuroimaging to gain insight into the pathophysiology of cerebral small vessel disease » - #22 Marc Suárez-Calvet
Barcelonaβeta Brain Research Center, Spain
« New plasma biomarkers related to PET imaging » - #23 Alexa Pichet Binette
Lund University, Sweden
« Associations between misfolded alpha-synuclein aggregates and Alzheimer’s disease pathology in vivo »
6. Modifiable risk and protective factors and non-pharmacological interventions
- #24 Federica Agosta
Vita-Salute San Raffaele University, Italy
« Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapies: risk factors, symptomatology and monitoring recommendations » - #25 Emrah Düzel
Otto-von-Guericke University Magdeburg, DZNE Magdeburg, Germany
« Targeting dysfunction in episodic memory circuitry in Alzheimer’s disease» - #26 Gaël Chételat
Inserm-Université de Caen, France
« Enhancing Brain Health: The Preventive Potential of Meditation against Neurodegenerative Diseases » - #27 Simon Cox
University of Edinburgh, Scotland
« Dementia and Cognitive Ageing in the Lothian Birth Cohorts » - #28 Eider Arenaza-Urquijo
Barcelona Institute for Global Health, Spain
« From the individual to the environment: understanding cognitive and brain resilience in aging »